Literature DB >> 21135387

The contribution of MRI in assessing cognitive impairment in multiple sclerosis.

M Filippi1, M A Rocca, R H B Benedict, J DeLuca, J J G Geurts, S A R B Rombouts, M Ron, G Comi.   

Abstract

Cognitive impairment affects a large proportion of patients with multiple sclerosis (MS) and has a profound impact on their daily-life activities. Improving the knowledge of the pathophysiology of cognitive impairment in MS and of the mechanisms responsible for its evolution over time might contribute to development of better outcome measures and targets for innovative treatment strategies. Due to their ability to detect MS-related abnormalities, MRI techniques are a valuable tool to achieve these goals. Following an updated overview of the assessment methods and profile of cognitive impairment in patients with MS, this review provides a state-of-the-art summary of the main results obtained from the application of conventional and modern magnetic resonance- based techniques to quantify MS-related damage, in terms of macroscopic lesions, as well as involvement of the normal-appearing white matter and gray matter and their association with cognitive impairment. The possible role of brain cortical reorganization in limiting the clinical consequences of disease-related damage is also discussed. Finally, the utility of the previous techniques to monitor the progression of cognitive deficits over time and the efficacy of possible therapeutic strategies is considered.

Entities:  

Mesh:

Year:  2010        PMID: 21135387      PMCID: PMC3385423          DOI: 10.1212/WNL.0b013e318200d768

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  59 in total

Review 1.  MRI markers of destructive pathology in multiple sclerosis-related cognitive dysfunction.

Authors:  Marco Rovaris; Giancarlo Comi; Massimo Filippi
Journal:  J Neurol Sci       Date:  2006-04-19       Impact factor: 3.181

2.  Neuropsychological assessment, quantitative MRI and ApoE gene polymorphisms in a series of MS patients treated with IFN beta-1b.

Authors:  Roberta Lanzillo; Anna Prinster; Valentina Scarano; Raffaele Liuzzi; Giovanni Coppola; Ciro Florio; Elena Salvatore; Vittorio Schiavone; Arturo Brunetti; Mario Muto; Giuseppe Orefice; Bruno Alfano; Vincenzo Bonavita; Vincenzo Brescia Morra
Journal:  J Neurol Sci       Date:  2006-04-19       Impact factor: 3.181

3.  Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS.

Authors:  Katrin Morgen; Gebhard Sammer; Susan M Courtney; Tobias Wolters; Hanne Melchior; Carlo R Blecker; Patrick Oschmann; Manfred Kaps; Dieter Vaitl
Journal:  Neuroimage       Date:  2005-12-15       Impact factor: 6.556

4.  Magnetic resonance spectroscopy of memory and frontal brain region in early multiple sclerosis.

Authors:  Wolfgang Staffen; Harald Zauner; Aldis Mair; Andrea Kutzelnigg; Peter Kapeller; Hilde Stangl; Edith Raffer; Helmut Niederhofer; Gunther Ladurner
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2005       Impact factor: 2.198

5.  Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).

Authors:  Ralph H B Benedict; Diane Cookfair; Rebecca Gavett; Mark Gunther; Frederick Munschauer; Neeta Garg; Bianca Weinstock-Guttman
Journal:  J Int Neuropsychol Soc       Date:  2006-07       Impact factor: 2.892

6.  fMRI study of episodic memory in relapsing-remitting MS: correlation with T2 lesion volume.

Authors:  J A Bobholz; S M Rao; L Lobeck; C Elsinger; A Gleason; J Kanz; S Durgerian; E Maas
Journal:  Neurology       Date:  2006-11-14       Impact factor: 9.910

7.  Donepezil improved memory in multiple sclerosis in a randomized clinical trial.

Authors:  L B Krupp; C Christodoulou; P Melville; W F Scherl; W S MacAllister; L E Elkins
Journal:  Neurology       Date:  2004-11-09       Impact factor: 9.910

8.  Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging.

Authors:  Jeroen J G Geurts; Petra J W Pouwels; Bernard M J Uitdehaag; Chris H Polman; Frederik Barkhof; Jonas A Castelijns
Journal:  Radiology       Date:  2005-07       Impact factor: 11.105

9.  Cortical demyelination and diffuse white matter injury in multiple sclerosis.

Authors:  Alexandra Kutzelnigg; Claudia F Lucchinetti; Christine Stadelmann; Wolfgang Brück; Helmut Rauschka; Markus Bergmann; Manfred Schmidbauer; Joseph E Parisi; Hans Lassmann
Journal:  Brain       Date:  2005-10-17       Impact factor: 13.501

10.  Acquisition and storage deficits in multiple sclerosis.

Authors:  J DeLuca; E A Gaudino; B J Diamond; C Christodoulou; R A Engel
Journal:  J Clin Exp Neuropsychol       Date:  1998-06       Impact factor: 2.475

View more
  52 in total

1.  Non-Gaussian diffusion MRI of gray matter is associated with cognitive impairment in multiple sclerosis.

Authors:  M Bester; J H Jensen; J S Babb; A Tabesh; L Miles; J Herbert; R I Grossman; M Inglese
Journal:  Mult Scler       Date:  2014-11-12       Impact factor: 6.312

2.  Increased functional connectivity indicates the severity of cognitive impairment in multiple sclerosis.

Authors:  David J Hawellek; Joerg F Hipp; Christopher M Lewis; Maurizio Corbetta; Andreas K Engel
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

3.  Functional connectivity changes in multiple sclerosis patients: a graph analytical study of MEG resting state data.

Authors:  Menno M Schoonheim; Jeroen J G Geurts; Doriana Landi; Linda Douw; Marieke L van der Meer; Hugo Vrenken; Chris H Polman; Frederik Barkhof; Cornelis J Stam
Journal:  Hum Brain Mapp       Date:  2011-09-23       Impact factor: 5.038

4.  Brain networks disconnection in early multiple sclerosis cognitive deficits: an anatomofunctional study.

Authors:  Céline Louapre; Vincent Perlbarg; Daniel García-Lorenzo; Marika Urbanski; Habib Benali; Rana Assouad; Damien Galanaud; Léorah Freeman; Benedetta Bodini; Caroline Papeix; Ayman Tourbah; Catherine Lubetzki; Stéphane Lehéricy; Bruno Stankoff
Journal:  Hum Brain Mapp       Date:  2014-03-31       Impact factor: 5.038

5.  Decreased frontal lobe gray matter perfusion in cognitively impaired patients with secondary-progressive multiple sclerosis detected by the bookend technique.

Authors:  R I Aviv; P L Francis; R Tenenbein; P O'Connor; L Zhang; A Eilaghi; L Lee; T J Carroll; J Mouannes-Srour; A Feinstein
Journal:  AJNR Am J Neuroradiol       Date:  2012-04-26       Impact factor: 3.825

6.  Normal-appearing white matter permeability distinguishes poor cognitive performance in processing speed and working memory.

Authors:  A Eilaghi; A Kassner; I Sitartchouk; P L Francis; R Jakubovic; A Feinstein; R I Aviv
Journal:  AJNR Am J Neuroradiol       Date:  2013-05-30       Impact factor: 3.825

7.  Searching for the neural basis of reserve against memory decline: intellectual enrichment linked to larger hippocampal volume in multiple sclerosis.

Authors:  J F Sumowski; M A Rocca; V M Leavitt; G Riccitelli; J Sandry; J DeLuca; G Comi; M Filippi
Journal:  Eur J Neurol       Date:  2015-02-04       Impact factor: 6.089

8.  Regional reduction in cortical blood flow among cognitively impaired adults with relapsing-remitting multiple sclerosis patients.

Authors:  Seyed-Parsa Hojjat; Charles Grady Cantrell; Rita Vitorino; Anthony Feinstein; Zahra Shirzadi; Bradley J MacIntosh; David E Crane; Lying Zhang; Sarah A Morrow; Liesly Lee; Paul O'Connor; Timothy J Carroll; Richard I Aviv
Journal:  Mult Scler       Date:  2016-01-11       Impact factor: 6.312

9.  Introduction: cognitive dysfunction in multiple sclerosis.

Authors:  Ralph H B Benedict; Kathleen Fuchs
Journal:  Int J MS Care       Date:  2012

10.  A simple measure of cognitive reserve is relevant for cognitive performance in MS patients.

Authors:  Marida Della Corte; Gabriella Santangelo; Alvino Bisecco; Rosaria Sacco; Mattia Siciliano; Alessandro d'Ambrosio; Renato Docimo; Teresa Cuomo; Luigi Lavorgna; Simona Bonavita; Gioacchino Tedeschi; Antonio Gallo
Journal:  Neurol Sci       Date:  2018-05-04       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.